GRI Bio, Inc.
GRI
$1.98
$0.031.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.15M | 4.56M | 4.92M | 4.47M | 4.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | 0.00 |
| Total Operating Expenses | 11.27M | 10.03M | 9.39M | 8.24M | 8.31M |
| Operating Income | -11.27M | -10.03M | -9.39M | -8.24M | -8.31M |
| Income Before Tax | -15.10M | -13.87M | -13.23M | -12.07M | -8.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.10 | -13.87 | -13.23 | -12.07 | -8.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.10M | -13.87M | -13.23M | -12.07M | -8.26M |
| EBIT | -11.27M | -10.03M | -9.39M | -8.24M | -8.31M |
| EBITDA | -11.26M | -10.03M | -9.39M | -8.23M | -8.30M |
| EPS Basic | -16.25 | -26.39 | -86.92 | -182.23 | -293.45 |
| Normalized Basic EPS | -7.72 | -14.06 | -51.90 | -111.46 | -108.98 |
| EPS Diluted | -24.11 | -34.25 | -94.79 | -190.09 | -293.45 |
| Normalized Diluted EPS | -7.72 | -14.06 | -51.90 | -111.46 | -108.98 |
| Average Basic Shares Outstanding | 5.84M | 3.41M | 1.24M | 732.00K | 241.00K |
| Average Diluted Shares Outstanding | 5.84M | 3.41M | 1.24M | 732.00K | 259.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |